Small cell neuroendocrine carcinoma: A rare second primary malignancy after treatment of nasopharyngeal carcinoma
, , , und
25. Juli 2018
Über diesen Artikel
Online veröffentlicht: 25. Juli 2018
Seitenbereich: 187 - 192
Eingereicht: 20. Mai 2018
Akzeptiert: 12. Juni 2018
DOI: https://doi.org/10.2478/rjr-2018-0021
Schlüsselwörter
© 2018 Krishnamoorthy Madhusudhan et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Small cell neuroendocrine carcinoma (SCNEC) of the nasopharynx and nasal cavity is a rare condition. It is an aggressive malignancy with a high recurrence rate. Despite its rarity in the sinonasal region, it may occur as a second primary malignancy. Patients with cancer of the head and neck region are more prone to develop a second primary tumor due to the field cancerization phenomenon, and a higher incidence is seen in those who have previously received radiation therapy. A detailed clinical and histopathological examination is pivotal to diagnose SCNEC as a second primary malignancy. We wish to highlight such a peculiar case from our center.